By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Integromics will use a €1 million ($1.3 million) grant from the European Regional Development Fund and the Spanish government to fund a partnership with the Galician Foundation of Genomic Medicine to develop data-focused clinical genomics solutions and software.

The project, called ApliClinics LC-NGS, will focus on developing ways to better analyze and interpret the large volumes of data generated by next-generation sequencing for clinical applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.